EP1 RECEPTOR LIGANDS

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation to their use as medicament for the treatment...

Full description

Saved in:
Bibliographic Details
Main Authors SALAS SOLANA JORDI, RODRÍGUEZ GARRIDO ANTONIO DAVID, MERCÈ VIDAL RAMON, TORRENS JOVER ANTONI, CALDENTEY FRONTERA FRANCESC XAVIER, CARCELLER GONZÁLEZ ELENA
Format Patent
LanguageEnglish
Published 03.07.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.
Bibliography:Application Number: IN2014MUMNP697